Jubilant Pharmova’s arm wins over Bracco’s legal appeals in United States Court of Appeals

10 May 2021 Evaluate

Jubilant Pharmova’s subsidiary -- Jubilant Pharma (Jubilant) has received a favorable and unanimous judgment from the United States Court of Appeals summarily affirming Jubilant’s earlier favorable rulings from the US Patent Office (PTAB) and the US International Trade Commission (ITC). These two rulings by the Appellate Court deny the appeals filed by Bracco Diagnostics, Inc (Bracco).

Jubilant successfully challenged Bracco’s patent infringement claims in an Inter Parties Review (IPR) proceeding before the US Patent Office as well as in a separate proceeding in the ITC. In both instances, Jubilant was successful. Despite the rulings of both the PTAB and the ITC, Bracco filed appeals to the US Court of Appeals in Washington D.C. These appeals are now dismissed.

Jubilant Pharmova (formerly Jubilant Life Sciences Limited) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.

Jubilant Pharmova Share Price

1038.30 -38.10 (-3.54%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×